"With presidential candidates on both sides of the aisle actively talking about unsustainable prescription drug pricing, the issue is clearly bigger than politics — it’s about protecting American families and ensuring they can access the critical treatments they need at prices they can afford." Read More
"Simply put, voters are looking for relief from astronomical drug prices and favor candidates who understand this is a pocketbook issue for American families," said John Rother, executive director of the coalition. Read More
As prescription drugs become increasingly expensive, the issue of unsustainable drug pricing is quickly becoming a central focus of the 2016 Presidential election. Last week, the Campaign for Sustainable Rx Pricing brought together policy experts and voters to discuss potential solutions during a panel discussion at Drake University. Read More
What The Candidates Are Saying… As the 2016 presidential race heats up,… Read More
Join the Campaign for Sustainable Rx Pricing for a panel discussion on the issue of skyrocketing prescription drug prices and broader challenges ahead for Iowa and the U.S. health care system. Read More
“Just as consumers are feeling the unsustainable cost pressure on prescription medications, so are the hospitals that purchase these essential, lifesaving prescription drugs for our patients in our care,” said Chip Kahn, President and CEO of the Federation of American Hospitals. Read More
Report: Prescription Drug Spending Tops Year-Over-Year Price Growth for Major… Read More
Exorbitant price tags associated with breakthrough treatments illustrate the broader challenges ahead for the U.S. health care system if excessive drug pricing is not addressed head on. Read More
Express Scripts has reached deals to cover two costly new cholesterol drugs and expects to spend roughly $750 million on them next year. Read More
As the 2016 presidential race heats up, prominent candidates are beginning to unveil comprehensive plans to address soaring prescription drug costs and the harmful impact their price tags have on Americans. Read More
"This latest health care price growth report indicates that spending on pricey prescription medications shows no sign of slowing down. When compared to other health care services, it is clear that high cost treatments continue to top the charts as a serious threat to the sustainability of our health care system and beyond." Read More
"The approval of Repatha is another example of a breakthrough medication with a too high price tag. With several game-changing medications in the pipeline, we need to address the underlying issue of how these prices are set from the start before they hit the market.” Read More